{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:54:18Z","timestamp":1791276858321,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":645,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy - Nucleic Acids"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1038\/mtna.2015.1","type":"journal-article","created":{"date-parts":[[2015,2,17]],"date-time":"2015-02-17T16:15:11Z","timestamp":1424189711000},"page":"e228","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["High-affinity RNA Aptamers Against the HIV-1 Protease Inhibit Both In Vitro Protease Activity and Late Events of Viral Replication"],"prefix":"10.1016","volume":"4","author":[{"given":"Sonald","family":"Duclair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ellington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayaka R","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mtna.2015.1_bib1","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1073\/pnas.86.15.5781","article-title":"Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type-1","volume":"86","author":"Gottlinger","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.1_bib2","doi-asserted-by":"crossref","first-page":"6612","DOI":"10.1073\/pnas.85.18.6612","article-title":"Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin-A","volume":"85","author":"Seelmeier","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.1_bib3","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1128\/JVI.72.4.2846-2854.1998","article-title":"Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites","volume":"72","author":"Wiegers","year":"1998","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib4","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1128\/JVI.68.10.6782-6786.1994","article-title":"The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency","volume":"68","author":"Kaplan","year":"1994","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1126\/science.2405486","article-title":"A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation","volume":"247","author":"McQuade","year":"1990","journal-title":"Science"},{"key":"10.1038\/mtna.2015.1_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01310950","article-title":"Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor","volume":"120","author":"Sch\u00e4tzl","year":"1991","journal-title":"Arch Virol"},{"key":"10.1038\/mtna.2015.1_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev.biophys.27.1.249","article-title":"Inhibitors of HIV-1 protease: a major success of structure-assisted drug design","volume":"27","author":"Wlodawer","year":"1998","journal-title":"Annu Rev Biophys Biomol Struct"},{"key":"10.1038\/mtna.2015.1_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1359-6446(97)01053-2","article-title":"Clinically effective HIV-1 protease inhibitors","volume":"2","author":"Vacca","year":"1997","journal-title":"Drug Discov Today"},{"key":"10.1038\/mtna.2015.1_bib9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.1_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter. AIDS Clinical Trials Group Study 175 Study Team","volume":"335","author":"Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.1_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1023\/A:1008629608556","article-title":"Clinical pharmacology of HIV protease inhibitors: focus on saquinavir, indinavir, and ritonavir","volume":"19","author":"Hoetelmans","year":"1997","journal-title":"Pharm World Sci"},{"key":"10.1038\/mtna.2015.1_bib12","doi-asserted-by":"crossref","first-page":"10492","DOI":"10.1016\/S0021-9258(18)86974-5","article-title":"Comparison of the crystal structures and intersubunit interactions of human immunodeficiency and Rous sarcoma virus proteases","volume":"265","author":"Weber","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2015.1_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/prot.340100406","article-title":"Comparative analysis of the sequences and structures of HIV-1 and HIV-2 proteases","volume":"10","author":"Gustchina","year":"1991","journal-title":"Proteins"},{"key":"10.1038\/mtna.2015.1_bib14","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1515\/BC.2002.150","article-title":"Dimerization inhibitors of HIV-1 protease","volume":"383","author":"Boggetto","year":"2002","journal-title":"Biol Chem"},{"key":"10.1038\/mtna.2015.1_bib15","doi-asserted-by":"crossref","first-page":"15591","DOI":"10.1016\/S0021-9258(18)98445-0","article-title":"Dissociative inhibition of dimeric enzymes. Kinetic characterization of the inhibition of HIV-1 protease by its COOH-terminal tetrapeptide","volume":"266","author":"Zhang","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1038\/mtna.2015.1_bib16","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1515\/BC.1999.076","article-title":"Lipopeptides as dimerization inhibitors of HIV-1 protease","volume":"380","author":"Schramm","year":"1999","journal-title":"Biol Chem"},{"key":"10.1038\/mtna.2015.1_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1126\/science.2200121","article-title":"Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase","volume":"249","author":"Tuerk","year":"1990","journal-title":"Science"},{"key":"10.1038\/mtna.2015.1_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/346818a0","article-title":"In vitro selection of RNA molecules that bind specific ligands","volume":"346","author":"Ellington","year":"1990","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.1_bib19","doi-asserted-by":"crossref","first-page":"10388","DOI":"10.1021\/bi0507074","article-title":"Combinatorial selection, inhibition, and antiviral activity of DNA thioaptamers targeting the RNase H domain of HIV-1 reverse transcriptase","volume":"44","author":"Somasunderam","year":"2005","journal-title":"Biochemistry"},{"key":"10.1038\/mtna.2015.1_bib20","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.1073\/pnas.89.15.6988","article-title":"RNA pseudoknots that inhibit human-immunodeficiency-virus type-1 reverse-transcriptase","volume":"89","author":"Tuerk","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.1_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/viro.1995.1264","article-title":"Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool","volume":"209","author":"Allen","year":"1995","journal-title":"Virology"},{"key":"10.1038\/mtna.2015.1_bib22","first-page":"145","article-title":"In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1","volume":"34","author":"Yamamoto","year":"1995","journal-title":"Nucleic Acids Symp Ser"},{"key":"10.1038\/mtna.2015.1_bib23","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1017\/S1355838299991318","article-title":"In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1","volume":"5","author":"Duconge","year":"1999","journal-title":"RNA-Publ RNA Soc"},{"key":"10.1038\/mtna.2015.1_bib24","doi-asserted-by":"crossref","first-page":"5509","DOI":"10.1093\/nar\/21.23.5509","article-title":"Selective optimization of the Rev-binding element of HIV-1","volume":"21","author":"Giver","year":"1993","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib25","doi-asserted-by":"crossref","first-page":"12220","DOI":"10.1073\/pnas.92.26.12220","article-title":"Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands","volume":"92","author":"Jensen","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.1_bib26","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1128\/JVI.02626-09","article-title":"RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production","volume":"85","author":"Ramalingam","year":"2011","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib27","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1093\/nar\/25.14.2902","article-title":"In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein","volume":"25","author":"Lochrie","year":"1997","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib28","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1006\/bbrc.2002.6521","article-title":"Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein","volume":"291","author":"Kim","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mtna.2015.1_bib29","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0006-291X(02)00308-X","article-title":"Structural characterization of a 2'F-RNA aptamer that binds a HIV-1 SU glycoprotein, gp120","volume":"293","author":"Sayer","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mtna.2015.1_bib30","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1093\/nar\/gkp185","article-title":"Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cells","volume":"37","author":"Zhou","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib31","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/jb\/mvg047","article-title":"Structure\/function analysis of an RNA aptamer for hepatitis C virus NS3 protease","volume":"133","author":"Sekiya","year":"2003","journal-title":"J Biochem"},{"key":"10.1038\/mtna.2015.1_bib32","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4244\/EIJY14M06_01","article-title":"Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study","volume":"10","author":"Povsic","year":"2014","journal-title":"EuroIntervention"},{"key":"10.1038\/mtna.2015.1_bib33","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.1128\/JVI.76.13.6545-6557.2002","article-title":"Potent inhibition of human immunodeficiency virus type 1 replication by template analog reverse transcriptase inhibitors derived by SELEX (systematic evolution of ligands by exponential enrichment)","volume":"76","author":"Joshi","year":"2002","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib34","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1093\/nar\/gkf522","article-title":"Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1","volume":"30","author":"Chaloin","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ymthe.2005.01.013","article-title":"Aptamers directed to HIV-1 reverse transcriptase display greater efficacy over small hairpin RNAs targeted to viral RNA in blocking HIV-1 replication","volume":"11","author":"Joshi","year":"2005","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.1_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4161\/rna.3.4.3811","article-title":"Endogenous expression of an anti-TAR aptamer reduces HIV-1 replication","volume":"3","author":"Kolb","year":"2006","journal-title":"RNA Biol"},{"key":"10.1038\/mtna.2015.1_bib37","doi-asserted-by":"crossref","first-page":"66ra6","DOI":"10.1126\/scitranslmed.3001581","article-title":"An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice","volume":"3","author":"Neff","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1038\/mtna.2015.1_bib38","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1038\/mt.2012.158","article-title":"Robust suppression of HIV replication by intracellularly expressed reverse transcriptase aptamers is independent of ribozyme processing","volume":"20","author":"Lange","year":"2012","journal-title":"Mol Ther"},{"key":"10.1038\/mtna.2015.1_bib39","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/nbt1367","article-title":"Genetic therapies against HIV","volume":"25","author":"Rossi","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2015.1_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.virol.2010.12.039","article-title":"Stem cell-based anti-HIV gene therapy","volume":"411","author":"Kitchen","year":"2011","journal-title":"Virology"},{"key":"10.1038\/mtna.2015.1_bib41","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nm.1932","article-title":"Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells","volume":"15","author":"Mitsuyasu","year":"2009","journal-title":"Nat Med"},{"key":"10.1038\/mtna.2015.1_bib42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1089\/hum.2005.16.1065","article-title":"Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals","volume":"16","author":"Morgan","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mtna.2015.1_bib43","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.0608138103","article-title":"Gene transfer in humans using a conditionally replicating lentiviral vector","volume":"103","author":"Levine","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mtna.2015.1_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJMoa1300662","article-title":"Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV","volume":"370","author":"Tebas","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1038\/mtna.2015.1_bib45","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1093\/nar\/gkp663","article-title":"Aptamers that recognize drug-resistant HIV-1 reverse transcriptase (vol 36, pg 6739, 2008)","volume":"37","author":"Li","year":"2009","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib46","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1093\/nar\/gkg595","article-title":"Mfold web server for nucleic acid folding and hybridization prediction","volume":"31","author":"Zuker","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.canlet.2005.06.007","article-title":"Cathepsin D: newly discovered functions of a long-standing aspartic protease in cancer and apoptosis","volume":"237","author":"Liaudet-Coopman","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1038\/mtna.2015.1_bib48","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"He","year":"1995","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib49","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/nar\/gkm103","article-title":"Optimization and characterization of tRNA-shRNA expression constructs","volume":"35","author":"Scherer","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mtna.2015.1_bib50","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nbt0502-500","article-title":"Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells","volume":"20","author":"Lee","year":"2002","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mtna.2015.1_bib51","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/pro.131434","article-title":"HIV-1 protease molecular dynamics of a wild-type and of the V82F\/I84V mutant: Possible contributions to drug resistance and a potential new target site for drugs (vol 13, pg 1108, 2004)","volume":"13","author":"Perryman","year":"2004","journal-title":"Protein Sci"},{"key":"10.1038\/mtna.2015.1_bib52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drudis.2006.12.011","article-title":"Targeting structural flexibility in HIV-1 protease inhibitor binding","volume":"12","author":"Hornak","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1038\/mtna.2015.1_bib53","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/337615a0","article-title":"Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1","volume":"337","author":"Navia","year":"1989","journal-title":"Nature"},{"key":"10.1038\/mtna.2015.1_bib54","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1126\/science.2548279","article-title":"Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease","volume":"245","author":"Wlodawer","year":"1989","journal-title":"Science"},{"key":"10.1038\/mtna.2015.1_bib55","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/prot.10246","article-title":"HIVdb: a database of the structures of human immunodeficiency virus protease","volume":"49","author":"Vondrasek","year":"2002","journal-title":"Proteins"},{"key":"10.1038\/mtna.2015.1_bib56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nsb0495-274","article-title":"Flexibility and function in HIV-1 protease","volume":"2","author":"Nicholson","year":"1995","journal-title":"Nat Struct Biol"},{"key":"10.1038\/mtna.2015.1_bib57","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1110\/ps.33202","article-title":"Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations","volume":"11","author":"Freedberg","year":"2002","journal-title":"Protein Sci"},{"key":"10.1038\/mtna.2015.1_bib58","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0969-2126(99)80172-5","article-title":"Flap opening and dimer-interface flexibility in the free and inhibitor-bound HIV protease, and their implications for function","volume":"7","author":"Ishima","year":"1999","journal-title":"Structure"},{"key":"10.1038\/mtna.2015.1_bib59","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.chembiol.2005.02.004","article-title":"Switching between allosteric and dimerization inhibition of HIV-1 protease","volume":"12","author":"Bowman","year":"2005","journal-title":"Chem Biol"},{"key":"10.1038\/mtna.2015.1_bib60","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jsb.2004.11.009","article-title":"Crystal structure of a cross-reaction complex between an anti-HIV-1 protease antibody and an HIV-2 protease peptide","volume":"149","author":"Rezacova","year":"2005","journal-title":"J Struct Biol"},{"key":"10.1038\/mtna.2015.1_bib61","doi-asserted-by":"crossref","first-page":"7789","DOI":"10.1128\/JVI.00473-09","article-title":"Modulation of human immunodeficiency virus type 1 protease autoprocessing by charge properties of surface residue 69","volume":"83","author":"Huang","year":"2009","journal-title":"J Virol"},{"key":"10.1038\/mtna.2015.1_bib62","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-59745-557-2_1","article-title":"Nucleic acid pool preparation and characterization","volume":"535","author":"Piasecki","year":"2009","journal-title":"Methods Mol Biol"},{"key":"10.1038\/mtna.2015.1_bib63","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"}],"container-title":["Molecular Therapy - Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253116300154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,30]],"date-time":"2022-04-30T00:02:15Z","timestamp":1651276935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253116300154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":63,"alternative-id":["S2162253116300154"],"URL":"https:\/\/doi.org\/10.1038\/mtna.2015.1","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2015]]},"article-number":"e228"}}